Amber V. Buhler, Ph.D. - Publications
Affiliations: | 2001 | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Pharmacology, Neuroscience BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2008 | Buhler AV, Proudfit HK, Gebhart GF. Neurotensin-produced antinociception in the rostral ventromedial medulla is partially mediated by spinal cord norepinephrine. Pain. 135: 280-90. PMID 17664042 DOI: 10.1016/J.Pain.2007.06.010 | 0.388 | |||
2006 | Zhang L, Sykes KT, Buhler AV, Hammond DL. Electrophysiological heterogeneity of spinally projecting serotonergic and nonserotonergic neurons in the rostral ventromedial medulla. Journal of Neurophysiology. 95: 1853-63. PMID 16338998 DOI: 10.1152/Jn.00883.2005 | 0.351 | |||
2005 | Buhler AV, Choi J, Proudfit HK, Gebhart GF. Neurotensin activation of the NTR1 on spinally-projecting serotonergic neurons in the rostral ventromedial medulla is antinociceptive. Pain. 114: 285-94. PMID 15733655 DOI: 10.1016/J.Pain.2004.12.031 | 0.381 | |||
2002 | Buhler AV, Dunwiddie TV. alpha7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons. Journal of Neurophysiology. 87: 548-57. PMID 11784770 DOI: 10.1152/Jn.00316.2001 | 0.607 | |||
2001 | Buhler AV, Dunwiddie TV. Regulation of the activity of hippocampal stratum oriens interneurons by alpha7 nicotinic acetylcholine receptors. Neuroscience. 106: 55-67. PMID 11564416 DOI: 10.1016/S0306-4522(01)00257-3 | 0.607 | |||
1998 | Frazier CJ, Buhler AV, Weiner JL, Dunwiddie TV. Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 8228-35. PMID 9763468 DOI: 10.1523/Jneurosci.18-20-08228.1998 | 0.59 | |||
1998 | Weiner JL, Buhler AV, Whatley VJ, Harris RA, Dunwiddie TV. Colchicine is a competitive antagonist at human recombinant gamma-aminobutyric acidA receptors. The Journal of Pharmacology and Experimental Therapeutics. 284: 95-102. PMID 9435166 | 0.543 | |||
Show low-probability matches. |